BioSolar to raise $5m in bid to significantly reduce electrolyser cost

BioSolar has showcased its desire to aggressively expand and accelerate the development of its electrolyser technology in a bid to lower the cost of green hydrogen production by entering into a securities purchase agreement with a single institutional investor.

The US company announced the news on Monday (5th April) and said gross proceeds from the offering are expected to be $5m.

With contemporary electrolysers relying on expensive, rare earth materials such as platinum and iridium, BioSolar’s technology is aimed at significantly reducing or replacing rare earth materials in electrolysers.

The materials will be replaced with inexpensive earth abundant materials to help usher in a green hydrogen economy that Goldman Sachs estimates will be worth $12 trillion by 2050 with the company using the net proceeds for working capital and general corporate purposes.

... to continue reading you must be subscribed

Subscribe Today

Paywall Asset Header Graphic

To gain access to this article and all our other content, you will need to subscribe to H2 View.

From the latest print editions, to 24/7 online access to exclusive interviews, authoritative columnists and the H2 View news archive, a subscription is the best way for you to stay up to date with developments in the hydrogen community.

Please wait...